Apogee Therapeutics, Inc.
USD134.18
+0.03 (+0.02%)
CEO
Michael Thomas Henderson
IPO Date
2023-07-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$134.15
Prev. Close
$134.15
Day Low
$134.11
Day High
$134.34
52W Low
$34.34
52W High
$134.44
Market Cap
$8.30B
Volume
0.17M
| 20,000 |
| $133.63 |
| 10 Jul 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | G-Gift | Disposed | 75,046 | $0.00 |
| 2 Jul 2026 | Dambkowski Carl | Chief Medical Officer | M-Exempt | Acquired | 4,125 | $22.86 |
| 2 Jul 2026 | Dambkowski Carl | Chief Medical Officer | S-Sale | Disposed | 5,500 | $132.74 |
| 2 Jul 2026 | Dambkowski Carl | Chief Medical Officer | M-Exempt | Disposed | 4,125 | $22.86 |
| 24 Jun 2026 | Dambkowski Carl | Chief Medical Officer | S-Sale | Disposed | 26,400 | $132.60 |
| 24 Jun 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | Disposed | 80,000 | $132.54 |
| 12 Jun 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | Disposed | 6,770 | $82.21 |
| 12 Jun 2026 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | Disposed | 7,654 | $82.78 |